.jpg?format=webp&width=780)
The objective of this study was to compare the efficacy of Itraconazole and systemic steroids as adjuvant to topical steroids in post‐operative patients with Allergic Fungal Rhinosinusitis (AFRS) using both subjective and objective outcome measurements. Itraconazole was comparable to Methylprednisolone in preventing disease recurrence in the post‐operative management of AFRS. Therefore, it may be a viable alternative to replacing systemic steroids where the latter may be contraindicated. Itraconazole, given at a dose of 400 mg once daily for six weeks, was a safe dose.
Like
Save
Share